Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000315066-05-000980
Filing Date
2005-02-14
Accepted
2005-02-14 09:19:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 DOC ONE filing.txt SC 13G 11929
  Complete submission text file 0000315066-05-000980.txt   13914
Mailing Address 82 DEVONSHIRE STREET BOSTON MA 02109
Business Address 82 DEVONSHIRE ST BOSTON MA 02109 6175706339
FMR CORP (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 161144965 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Subject) CIK: 0001018710 (see all company filings)

EIN.: 742704230 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-61001 | Film No.: 05602939
SIC: 2834 Pharmaceutical Preparations